Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
Name | Price | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
DNA-PKcs (pT2647) Blocking Peptide | Login | DNA-PKcs (pT2647) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
RAD51A (pY315) Blocking Peptide | Login | RAD51A (pY315) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
RAD51A Blocking Peptide | Login | RAD51A Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
c-RAF (pS43) Blocking Peptide | Login | c-RAF (pS43) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
c-RAF Blocking Peptide | Login | c-RAF Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
c-Raf/B-RAF (pT491/599) Blocking Peptide | Login | c-Raf/B-RAF (pT491/599) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
CTIP Blocking Peptide | Login | CTIP Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
NF-kappaB p65 Blocking Peptide | Login | NF-kappaB p65 Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
MSK1 Blocking Peptide | Login | MSK1 Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
SMAD3 (pS213) Blocking Peptide | Login | SMAD3 (pS213) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
SSTR1 Blocking Peptide | Login | SSTR1 Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
LKB1 (pT189) Blocking Peptide | Login | LKB1 (pT189) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
p67 Blocking Peptide | Login | p67 Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
TIE2 (pY992) Blocking Peptide | Login | TIE2 (pY992) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
TIE2 Blocking Peptide | Login | TIE2 Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
TNFAIP8L2 Blocking Peptide | Login | TNFAIP8L2 Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
USP38 Blocking Peptide | Login | USP38 Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
Angiopoietin-1 Blocking Peptide | Login | Angiopoietin-1 Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
Caspase 8 p18 Blocking Peptide | Login | Caspase 8 p18 Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
Cathepsin B Blocking Peptide | Login | Cathepsin B Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
Glucocorticoid Receptor Blocking Peptide | Login | Glucocorticoid Receptor Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
hnRNP L Blocking Peptide | Login | hnRNP L Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
MENA Blocking Peptide | Login | MENA Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
Histone H4 (AcK5) Blocking Peptide | Login | Histone H4 (AcK5) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
c-Met Blocking Peptide | Login | c-Met Blocking Peptide | ||||||||||||||||
|